Glycated Hemoglobin Testing Market will reach US$5.16 Billion by 2033 - Strategic Revenue Insights

London, UK – November 2025 | Strategic Revenue Insights Inc. – The global Glycated Hemoglobin Testing market is set to accelerate dramatically in the coming years, with fresh analysis from Strategic Revenue Insights estimating the sector will rise from USD 2.10 billion in 2024 to USD 5.16 billion by 2033, reflecting a robust compound annual growth rate (CAGR) of 10.5%.

Since 2018 the Glycated Hemoglobin Testing market has seen a steady climb  expanding from roughly USD 1.27 billion to USD 2.10 billion by 2024 (historical CAGR ~8%). This growth has been fueled by the surging prevalence of diabetes worldwide, which continues to amplify demand for reliable and regular long-term glucose monitoring solutions through HbA1c testing.

A comprehensive assessment of this rapidly evolving market can be accessed through Strategic Revenue Insights at the link below, focused on Glycated Hemoglobin Testing:

https://www.strategicrevenueinsights.com/industry/glycated-hemoglobin-testing-market

Rising incidence of type 2 diabetes driven by changing lifestyles, aging populations, and growing metabolic disorders remains the primary growth engine behind Glycated Hemoglobin Testing demand. As awareness grows among healthcare professionals and patients alike about the value of HbA1c in assessing long-term glycemic control, testing frequency increases, supporting market expansion. Alongside demand growth, innovations in testing technology  especially point-of-care (POC) devices  have improved accessibility and turnaround time, enabling broader adoption in outpatient settings, clinics, and remote regions. At the same time, expanding healthcare infrastructure globally and increased investment in diabetes management programmers particularly in emerging economies are enlarging the addressable market for HbA1c diagnostics.

Geographically, the market dynamics show notable regional variation. In advanced economies such as the United States and parts of Europe, well-established healthcare systems and widespread awareness ensure steady demand for glycated hemoglobin testing. Meanwhile, in emerging markets especially in Asia-Pacific and parts of Latin America rapidly rising diabetes prevalence, improving diagnostic infrastructure, and growing patient awareness are driving the fastest growth rates, positioning these regions as key future growth engines.

The market divides across several segments: by product type into laboratory-based HbA1c testing products and point-of-care (POC) HbA1c testing products; by technology including chromatography, immunoassay and other assay types; and by end-user  hospitals, physical examination institutions, research institutions and other healthcare settings.  Laboratory-based analyzers remain the staple for large clinical labs and hospitals due to their throughput and reliability, while POC devices are gaining traction in clinics and decentralized healthcare settings because of convenience and rapid results.

Browse the associated report:

https://www.strategicrevenueinsights.com/ja/industry/glycated-hemoglobin-testing-market

https://www.strategicrevenueinsights.com/kr/industry/glycated-hemoglobin-testing-market

https://www.strategicrevenueinsights.com/da/industry/glycated-hemoglobin-testing-market

https://www.strategicrevenueinsights.com/de/industry/glycated-hemoglobin-testing-market

https://www.strategicrevenueinsights.com/pt/industry/glycated-hemoglobin-testing-market

https://www.strategicrevenueinsights.com/it/industry/glycated-hemoglobin-testing-market

https://www.strategicrevenueinsights.com/es/industry/glycated-hemoglobin-testing-market

https://www.strategicrevenueinsights.com/fr/industry/glycated-hemoglobin-testing-market

Major players define the competitive landscape, offering broad product portfolios across analyzers, reagents and testing kits. These include Abbott Laboratories, F. Hoffmann‑La Roche Ltd., Beckman Coulter, Inc., Bayer AG, Bio‑Rad Laboratories, Inc., ARKRAY, Inc., Tosoh Corporation, along with several other global and regional diagnostic firms. These companies continue to invest in assay improvements, automation, and expansion of reagent supply networks to address rising global demand effectively.

Looking ahead to 2033, the Glycated Hemoglobin Testing market is likely to benefit not only from increasing numbers of patients requiring regular monitoring but also from structural shifts in healthcare delivery  including expanded use of POC testing, integration of HbA1c screening in preventive health programmers, and rising penetration of diabetes care protocols in emerging regions. Policy-driven initiatives to improve chronic disease management and growing emphasis on early diagnosis could further accelerate adoption. Innovations that reduce cost, simplify workflows, and enable decentralized testing especially in underserved regions will expand access and drive growth.

For stakeholders and investors, this represents a strong long-term growth opportunity. Demand for HbA1c analyzers, reagents, and point-of-care solutions will likely escalate. Companies that offer scalable, cost-effective, and reliable glycated hemoglobin testing solutions stand to gain significant share as the market more than doubles over the next eight years.

Related Reports:

https://www.strategicrevenueinsights.com/industry/menopause-wellness-market

https://www.strategicrevenueinsights.com/industry/lensometer-market

https://www.strategicrevenueinsights.com/industry/focal-segmental-glomerulosclerosis-fsgs-market

https://www.strategicrevenueinsights.com/industry/glioblastoma-multiforme-treatment-gbm-market

https://www.strategicrevenueinsights.com/industry/surgical-tables-market

About Strategic Revenue Insights Inc.

Strategic Revenue Insights Inc., a subsidiary of SRI Consulting Group Ltd, empowers organizations worldwide with data driven market intelligence. Headquartered in London, United Kingdom, the firm delivers syndicated research reports, tailored consulting solutions, and actionable insights that equip clients to make confident, future focused strategic decisions. Its team of seasoned analysts continuously tracks markets, identifies emerging trends, and uncovers growth opportunities to support long-term client success. As part of SRI Consulting Group Ltd, Strategic Revenue Insights Inc. is committed to accuracy, clarity, and practical relevance, helping businesses optimize strategies and accelerate revenue growth.

Media Contact

Company Name: Strategic Revenue Insights Inc.

Contact Person: Ashwani

Email: sales@strategicrevenueinsights.com

Phone: +44 7877 403352

Address: Suite 10, Capital House, 61 Amhurst Road, E8 1LL

City: London

Country: United Kingdom

Website: www.strategicrevenueinsights.com

Website: www.strategicpackaginginsights.com